Bharat Biotech Announces Price of Intranasal Covid Vaccine
Bharat Biotech’s intranasal coronavirus vaccine costs have been announced.
A single dosage of Bharat Biotech’s intranasal vaccine iNCOVACC, which was authorised for inclusion in India’s COVID-19 immunisation programme last week, would cost Rs 800, excluding the 5% Goods and Services Tax (GST) at private hospitals.
The nasal vaccination was authorised by the government last Friday as India prepared to deal with any crisis that arises as a result of the worldwide spike in coronavirus infections. It will be used as a heterologous booster and will be offered first in private institutions.
Where to apply for nasal vaccine?
Starting today, the vaccination will be available through the CoWIN app. In this context, the CoWIN platform will also be changed. Simply check in to your CoWIN account and apply for a vaccination slot. The vaccine will be offered in private hospitals beginning today and will be included in Covid-19 immunisation campaigns.
Who is eligible for nasal vaccine?
Those above the age of 18 can get the iNCOVACC nasal vaccine, which has been licenced by the Government of India and will be used as a heterologous booster dose.
When compared to injectable immunisations, nasal vaccines provide several advantages. Aside from the simplicity of storage, delivery, and waste creation, nasal vaccinations also give protection at the virus’s entrance locations – the nose or upper respiratory tract.
Also Read: COVID Mock Drills TO Take Place All Over India Today
Companies That Took Part in the making
The vaccine was created in collaboration with Washington University in St. Louis, which conceived and produced the recombinant adenoviral vectored construct and tested its effectiveness in preclinical tests.
Bharat Biotech developed products for preclinical safety review, large-scale manufacturing scale up, formulation and delivery device development, and human clinical trials.
The Government of India supported part of the product development and clinical testing through the Department of Biotechnology’s Covid Suraksha programme.
The government has encouraged people who are eligible to take the preventive dose and practise Covid-appropriate behaviour, such as masking and social distance.
On Thursday, Prime Minister Narendra Modi warned people not to be complacent and advised them to wear masks in crowded locations, while also urging officials to increase surveillance procedures, particularly at international airports.
